Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05121792 · ClinicalTrials.gov registry record · NA
Web Based Therapist Tutorial on Prolonged Grief
A NA study of Prolonged Grief Disorder, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 2
- Study locations
NCT05121792: Completed NA study of Prolonged Grief Disorder, sponsored by Columbia University.
NCT05121792 is a NA study of Prolonged Grief Disorder that has completed, run by Columbia University. The registered enrollment target is 400 participants, above the 78-participant average among 3 other Prolonged Grief Disorder trials with a reported enrollment target (413% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05121792, a NA study of Prolonged Grief Disorder, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
Death of a loved one is a difficult life experience. About 1 in 10 bereaved people are strongly affected by the loss and grieve intensely for a long time. As a result of the COVID-19 pandemic, more people may struggle with grief. The investigators have developed and tested a talk therapy for prolonged grief. The investigators have developed an online grief training for clinicians. The investigators will test if clinicians benefit from the online training and if they find it helpful and engaging. The investigators will recruit 30 mental health professionals as trainees to undergo the training. The mental health professionals will complete questionnaires before and after training to determine how much they learned and how much they liked the training.
Primary Outcome
The USQ evaluates participant satisfaction with the clinical content of web-based applications, and how effective the participant felt the learning was. The USQ contains 15 statements, each rated on a 4-point scale (strongly agree, agree, disagree, strongly disagree), and covers several dimensions of the user experience. It also solicits open-ended feedback. The scale ranges from 15 to 60, with a higher score indicating user satisfaction. The investigators will consider an overall mean score of
Conditions Studied
Interventions
- BEHAVIORAL Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy
Study Locations (2)
New York
- Center for Complicated Grief, Columbia School of Social Work - New York
Wisconsin
- Center for Psychological Consultation - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-10-28 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
What the finished NCT05121792 record still lists
NCT05121792 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 78-participant average among 3 other Prolonged Grief Disorder trials with a reported enrollment target (413% higher).
The record links to 1 condition, with Prolonged Grief Disorder appearing as the primary indexed condition, and to 1 intervention - of which Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy is the first listed.
NCT05121792 reports a single indexed study location in New York, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05121792 about?
NCT05121792 is a clinical study titled "Web Based Therapist Tutorial on Prolonged Grief". Death of a loved one is a difficult life experience. About 1 in 10 bereaved people are strongly affected by the loss and grieve intensely for a long time. As a result of the COVID-19 pandemic, more people may struggle with grief. The investigators have developed and tested a talk therapy for prolong...
What is the current status of trial NCT05121792?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2021-10-28. Estimated completion is 2022-06-15.
What conditions does trial NCT05121792 study?
This clinical trial studies the following conditions: Prolonged Grief Disorder.
What interventions are being tested in trial NCT05121792?
The interventions under investigation include: Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05121792?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05121792 being conducted?
This trial has 2 study locations across New York, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prolonged Grief Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI